Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Accumulated Expenses (2020 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Accumulated Expenses came in at $739033.0 in Q1 2026, down 33.88% YoY from $1.1 million in Q1 2025, and down 66.35% on a QoQ basis from $2.2 million in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) Accumulated Expenses (2020 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 7 years of Accumulated Expenses data on file, last reported at $739033.0 in Q1 2026.

  • Quarterly Accumulated Expenses fell 33.88% year-over-year to $739033.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $739033.0 (down 33.88% YoY) and the FY2025 annual result came in at $2.2 million, up 65.83% from the prior year.
  • Accumulated Expenses declined to $739033.0 in Q1 2026, from $2.2 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $2.2 million in Q4 2025 to a low of $34000.0 in Q1 2022.
  • A 5-year average of $673662.0 and a median of $579462.0 in 2024 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2023 — Accumulated Expenses plunged 63.5% — and 2024, when it surged 753.79%.
  • Tracing CNTN's Accumulated Expenses over 5 years: stood at $190468.0 in 2022, then soared by 375.92% to $906469.0 in 2023, then jumped by 46.1% to $1.3 million in 2024, then soared by 65.83% to $2.2 million in 2025, then plunged by 66.35% to $739033.0 in 2026.
  • The last three Accumulated Expenses figures came in at $739033.0 (Q1 2026), $2.2 million (Q4 2025), and $689804.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 983,715.00
Mar 31, 2026 739,033.00
Dec 31, 2025 506,460.00
Sep 30, 2025 689,804.00
Jun 30, 2025 1.06 Mn
Mar 31, 2025 1.12 Mn
Dec 31, 2024 1.32 Mn
Sep 30, 2024 1.37 Mn
Jun 30, 2024 579,462.00
Mar 31, 2024 527,527.00
Dec 31, 2023 906,469.00
Sep 30, 2023 190,293.00
Jun 30, 2023 67,869.00
Mar 31, 2023 242,220.00
Dec 31, 2022 190,468.00
Sep 30, 2022 179,871.00
Jun 30, 2022 185,944.00
Mar 31, 2022 218,885.00
Dec 31, 2021 318,223.00
Dec 31, 2020 73,066.00